Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
-
Clinical Benefit
Substantial
the actual benefit of SIGNIFOR is substancial for the management of adult patients in whom surgery is not an option or has failed.
Clinical Added Value
minor
The Transparency Committee defines the improvement in actual benefit for SIGNIFOR as minor (IAB level IV) for the management of Cushing's Disease in adult patients in whom surgery is not an option or has failed, compared to the current treatment strategy.